Tesla's European April Sales Drop Year Over Year-March 2024-www.financetom.com

Tesla's European April Sales Drop Year Over Year

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tesla's European April Sales Drop Year Over Year

May 22, 2024 5:22 AM

07:54 AM EDT, 05/22/2024 (MT Newswires) -- Tesla (TSLA) registered 13,951 vehicles during April in Europe, the European Free Trade Association region, and the UK, down from 14,278 a year earlier, the European Automobile Manufacturers' Association said Wednesday.

Price: 182.70, Change: -3.90, Percent Change: -2.09

Previous page： Avanos Medical Names David Pacitti CEO Next page： DuPont de Nemours Names Jon Kemp as CEO of Electronics Business Spin-Off

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Avanos Medical Names David Pacitti CEO

Mar 17, 2025

08:33 AM EDT, 03/17/2025 (MT Newswires) -- Avanos Medical ( AVNS ) said Monday that it has appointed David Pacitti as its new chief executive officer, effective April 14. Pacitti most recently served as president of Siemens Medical Solutions USA, and has held positions at Abbott Vascular and Guidant. ...

DuPont de Nemours Names Jon Kemp as CEO of Electronics Business Spin-Off

Mar 17, 2025

08:34 AM EDT, 03/17/2025 (MT Newswires) -- DuPont de Nemours ( DD ) said Monday that Jon Kemp will be the chief executive of the independent electronics public company after its planned spin-off from DuPont ( DD ). Kemp, currently president of DuPont Electronics & Industrial, will also be a member of the planned company's board, which will be chaired...

PepsiCo to buy soda brand Poppi for nearly $2 bln

Mar 17, 2025

March 17 (Reuters) - PepsiCo ( PEP ) said on Monday it would buy Poppi, a prebiotic soda brand, for $1.95 billion. (Reporting by Ananya Mariam Rajesh in Bengaluru; Editing by Sriraj Kalluvila) ...

Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use

Mar 17, 2025

08:31 AM EDT, 03/17/2025 (MT Newswires) -- Xeris Biopharma ( XERS ) said Monday that the US Food and Drug Administration has approved the company's supplemental new drug application for Gvoke VialDx for use as a diagnostic aid to temporarily inhibit gastrointestinal tract movement during radiologic examinations in adult patients. Xeris also said it has partnered with American Regent to...